Видео ютуба по тегу Pomalidomide

Long-term follow-up of belantamab mafodotin plus pomalidomide and dexamethasone in myeloma: DREAMM-8
Long-term follow-up of belantamab mafodotin plus pomalidomide and dexamethasone in myeloma: DREAMM-8
MonumenTAL-2 safety & efficacy results: talquetamab + pomalidomide in patients with RRMM
MonumenTAL-2 safety & efficacy results: talquetamab + pomalidomide in patients with RRMM
Belantamab mafodotin combined with pomalidomide and dexamethasone in RRMM: HRQoL in DREAMM-8
Belantamab mafodotin combined with pomalidomide and dexamethasone in RRMM: HRQoL in DREAMM-8
Phase II dose optimization study of inobrodib with pomalidomide and dexamethasone in R/R myeloma
Phase II dose optimization study of inobrodib with pomalidomide and dexamethasone in R/R myeloma
Belantamab plus pomalidomide and dexamethasone as a maintenance strategy for high-risk myeloma
Belantamab plus pomalidomide and dexamethasone as a maintenance strategy for high-risk myeloma
What combination regimens including BiTEs are being evaluated for the treatment of RRMM?
What combination regimens including BiTEs are being evaluated for the treatment of RRMM?
Subcutaneous vs IV isatuximab + pomalidomide/dexamethasone in R/R MM: IRAKLIA phase 3 study
Subcutaneous vs IV isatuximab + pomalidomide/dexamethasone in R/R MM: IRAKLIA phase 3 study
Updated DREAMM-8 Data: Belantamab-Pomalidomide-Dex in Myeloma | Meletios Dimopoulos, MD | #EHA2025
Updated DREAMM-8 Data: Belantamab-Pomalidomide-Dex in Myeloma | Meletios Dimopoulos, MD | #EHA2025
A Phase I trial of tagraxofusp combined with pomalidomide and dexamethasone in RRMM
A Phase I trial of tagraxofusp combined with pomalidomide and dexamethasone in RRMM
Final analysis of the OPTIMISMM trial: pomalidomide, bortezomib, and dexamethasone in RRMM
Final analysis of the OPTIMISMM trial: pomalidomide, bortezomib, and dexamethasone in RRMM
Updated results from DREAMM-8: belamaf plus pomalidomide and dexamethasone in R/R myeloma
Updated results from DREAMM-8: belamaf plus pomalidomide and dexamethasone in R/R myeloma
Myélome: Possibilite d'Interférence du lactate de magnésium avec Pomalyst et dexaméthasone?
Myélome: Possibilite d'Interférence du lactate de magnésium avec Pomalyst et dexaméthasone?
2025 CR Forum Top Ten| Pomalidomide for Bleeding in Patients with Hereditary Hemorrhagic
2025 CR Forum Top Ten| Pomalidomide for Bleeding in Patients with Hereditary Hemorrhagic
Can high-risk myeloma patients get to a point where they are no longer considered high-risk?
Can high-risk myeloma patients get to a point where they are no longer considered high-risk?
Safety and early activity of SL-401 plus pomalidomide in R/R multiple myeloma
Safety and early activity of SL-401 plus pomalidomide in R/R multiple myeloma
The tolerability and clinical activity of inobrodib plus pomalidomide and dexamethasone in RRMM
The tolerability and clinical activity of inobrodib plus pomalidomide and dexamethasone in RRMM
Pomalidomida: Innovación en el Tratamiento del Mieloma Múltiple Refractario
Pomalidomida: Innovación en el Tratamiento del Mieloma Múltiple Refractario
Testing The Combination of Talquetamab, Daratumab, and Pomalidomide To Treat Multiple Myeloma
Testing The Combination of Talquetamab, Daratumab, and Pomalidomide To Treat Multiple Myeloma
Pomalidomide Improved Immune Profiles in Myeloma | Oncoscience
Pomalidomide Improved Immune Profiles in Myeloma | Oncoscience
[메디컬투데이TV] 보령, 다발골수종 치료제 ‘포말리스트’ 퍼스트 제네릭 출시 임박
[메디컬투데이TV] 보령, 다발골수종 치료제 ‘포말리스트’ 퍼스트 제네릭 출시 임박
Combination of Selinexor, Pomalidomide, & Dexamethasone for RRMM | Muhamed Baljevic, MD | #ASH24
Combination of Selinexor, Pomalidomide, & Dexamethasone for RRMM | Muhamed Baljevic, MD | #ASH24
Inobrodib in Combination with Pomalidomide and Dexamethasone in Myeloma | Emma Searle, MD | #ASH24
Inobrodib in Combination with Pomalidomide and Dexamethasone in Myeloma | Emma Searle, MD | #ASH24
Using combination therapies with pomalidomide to overcome lenalidomide refractoriness in myeloma
Using combination therapies with pomalidomide to overcome lenalidomide refractoriness in myeloma
Dr. Glaucomflecken Explains: Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia
Dr. Glaucomflecken Explains: Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia
Phase II study of isatuximab, pomalidomide and dexamethasone in lenalidomide-exposed R/R myeloma
Phase II study of isatuximab, pomalidomide and dexamethasone in lenalidomide-exposed R/R myeloma